ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ジクロフェナクナトリウム

Diclofenac sodium

HCID 5018304
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
15307-79-6
標準SMILES
O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+]
InChIKey
KPHWPUGNDIVLNH-UHFFFAOYSA-M
分子式
C14H10Cl2NNaO2
平均分子量
318.1 g/mol
単同位体質量
316.9986282

概要

Diclofenac sodium is the sodium salt of diclofenac. It contains a diclofenac(1-).

名称と識別子

優先名称
Diclofenac sodium
IUPAC
sodium 2-[2-(2,6-dichloroanilino)phenyl]acetate
現地名
ジクロフェナクナトリウム
英語名
Diclofenac sodium
分子式
C14H10Cl2NNaO2
分子量
318.13

名称と別名

Diclofenac sodium15307-79-6Diclofenac sodium saltSodium diclofenacSolarazeNeriodinProphenatinVoltarenDiclophenac sodiumAbitrenBenfofenDyloject
名称をさらに表示
ジクロフェナクナトリウムジクロフェナックナトリウムアデフロニックo-(2,6-ジクロロアニリノ)フェニル酢酸ナトリウムネリオジンアデフロニック-LブレシンバレタンダイスパスドセルジクロスターPFボルタレンSRメクロフェンナボールSRサビスミンSRオルトフェンアスピゾンボルタロールストロングコールSRプロフェナチンtsudohminDiclofenac SodiuAceclofenac EP IMpurity ASODIUM 2-(2,6-DICHLOROANILINO)PHENYLACETATEsodium 2-[2-(2,6-dichloroanilino)phenyl]acetateN-(2,6-Dichlorophenyl)-o-aminophenylacetic acid sodium saltNaclof
EcofenacPennsaidVoltareneVoltaren-XRGP 45840DiclophlogontDealgicDeflamat

データベース識別子

物性

構造計算による物性

極性表面積
52.2 Ų
水素結合供与体数
1
水素結合受容体数
3
回転可能結合数
4
重原子数
20
形式電荷
0
複雑度
310

実験および物理化学的性質

Human Drugs · 3 件

Breast Feeding; Lactation; Milk, Human; Analgesic Agents; Anti-inflammatory Agents, Nonsteroidal

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsActive Ingredients (Diclofenac sodium) -> FDA Greenbook
Collision Cross Section157.2 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
288 · 288-290°C
比重(密度)
0.781 g/cm3 · 0.781 g/cm3
貯蔵温度
room temp
溶解性
2 O: · H2O: 50 mg/mL
酸解離定数(Pka)
4 · 4(at 25℃)
外見
白い固体
色
White to Almost white
由来生物
synthetic
水溶解度
50 mg/mlまで水に溶けます。 · 50mg/mlまで水に溶けます。
Merck
14 · 14,3081
BCS Class
2 · 2
安定性
安定。

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H301 (96.7%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 243 reports by companies from 43 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 2 件

Status: Active Update: 27-05-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/13423

Diclofenac sodium: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, monosodium salt: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (96.7%)

毒性情報

Exposure RoutesCompletely absorbed from the gastrointestinal tract.
Toxicity Summary · 1 件

The antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Hepatic. Route of Elimination: Diclofenac is eliminated through metabolism and subsequent urinary and biliary excretion of the glucuronide and the sulfate conjugates of the metabolites. Little or no free unchanged diclofenac is excreted in the urine. Approximately 65% of the dose is excreted in the urine and approximately 35% in the bile as conjugates of unchanged diclofenac plus metabolites. Half Life: 2 hours

FDA Pharmacological Classification · 6 件

DICLOFENAC SODIUM

Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Decreased Prostaglandin Production [PE]

DICLOFENAC SODIUM 1%

Cyclooxygenase Inhibitors [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]

DICLOFENAC SODIUM D/R

Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; Decreased Prostaglandin Production [PE]; Anti-Inflammatory Agents, Non-Steroidal [CS]

MeSH Pharmacological Classification · 2 件

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.

用途と製造

UsesFor the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.

関連反応

24 件
反応記録を作成
HRID 356790 の反応式
HRID 356790反応物として
HRID 371113 の反応式
HRID 371113反応物として
HRID 464711 の反応式
HRID 464711反応物として
HRID 990889 の反応式
HRID 990889反応物として
HRID 1360001 の反応式
HRID 1360001反応物として
HRID 1420867 の反応式
HRID 1420867反応物として
HRID 1517222 の反応式
HRID 1517222反応物として
HRID 1660668 の反応式
HRID 1660668反応物として
前へ1 / 3 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
CAS
15307-79-6
PubChem CID
5018304
DTXSID
DTXSID3037208
ChEMBL
CHEMBL1034
ChEBI
CHEBI:4509
UNII
QTG126297Q
EC Number
239-346-4
Nikkaji
J8.556A
主な用途
法医学と毒物学医薬品(低分子化合物)
InChI
InChI=1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1
InChIKey
KPHWPUGNDIVLNH-UHFFFAOYSA-M
SMILES
C1(=CC=CC=C1CC([O-])=O)NC1=C(Cl)C=CC=C1Cl.[Na+]
CAS データベース
15307 · 15307-79-6(CAS DataBase Reference)

化学的性質

化学的特性Off-White Crystalline Solid

Signs and SymptomsSymptoms of overdose include loss of consciousness, increased intracranial pressure, and aspiration pneumonitis.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Diclofenac sodium

vMost-DILI-concern

8

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD<sub>50</sub>=390mg/kg (orally in mice)

安全データ

wgk
3
rtecs
AG6330000
ridadr
UN 2811 6.1/PG 3
毒性
LD50 in mice, rats (mg/kg): ~390, 150 orally (Krupp)
hs_code
29224999
risk_code
25-36/37/38-63
hazard_code
T,Xi
safety_code
22-36/37-45-36-26-60-20
hazard_class
6.1(b)
packing_group
III
Hazard Classifications
Acute Tox. 3 OralAquatic Chronic 2Repr. 2STOT RE 1
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Use ClassificationAnimal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
応用分野 · 6 件

用途フェニル酢酸系化合物です。シクロオキシゲナーゼ(COX)を阻害し、プロスタグランジン生合成抑制作用を示します。

用途薬理・生理作用研究用。

説明Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 0.9-2.7 and 1.5-20 μM, for human COX-1 and COX-2, respectively). It is also an active metabolite of diclofenac methyl ester and diclofenac amide . Diclofenac inhibits release of arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) induced by A23187 in isolated rat peritoneal neutrophils and macrophages (IC50s = 60 and 10 μM, respectively). Transdermal administration of diclofenac inhibits carrageenan-induced paw edema in rats. Formulations containing diclofenac have been used in the treatment of pain associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

来歴Diclofenac sodium is a classic nonsteroidal anti-inflammatory drug (NSAID), known for its potent antipyretic, analgesic, and anti-inflammatory effects, and is marketed under brand names such as Voltaren. Its discovery and widespread use have had a profound impact on the treatment of pain and inflammation.Discovery and Patent (1965): Diclofenac sodium was synthesized by a team of researchers Rudolf Pfister and Alfred Sallmann at the Swiss pharmaceutical company Ciba-Geigy AG (now part of Novartis) while searching for a highly active and well-tolerated NSAID. The compound was patented in 1965.First Market Launch (1973): After extensive preclinical and clinical trials, diclofenac sodium was first marketed globally in 1973 under the brand name Voltaren. Its design philosophy is based on clear principles and aims to be an effective cyclooxygenase (COX) inhibitor.

使用Diclofenac sodium is a nonsteroidal anti-inflammatory compound and cyclooxygenase (COX) inhibitor. Oxidation of diclofenac sodium produces the metabolite 4'-hydroxy diclofenac) which demonstrates specific inhibition of Cox-2. Inhibition of Cox by diclofenac and 4'-hydroxy diclofenac suppresses prostaglandin E2 synthesis, producing anti-inflammatory and analgesic effects. Diclofenac is also shown to stabilize the native tetrameric conformation of transthyretin (TTR) fibrils, preventing the formation of insoluble amyloidogenic TTR deposits. Diclofenac Sodium is a substrate of CYP2C9. It is also used as an inhibitor of Cox-1 and Cox-2.

一般的な説明Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Diclofenac is a derivative of benzeneacetic acid. It is categorized under the class of non-steroidal anti-inflammatory drugs (NSAIDs). It shows inflammatory, analgesic and antipyretic activities.

上流・下流製品情報

上流原料

エタノールクロロアセチルクロリド2,6-ジクロロフェノール2-クロロ安息香酸アニリン2,5-ジクロロアニリン2-クロロトルエン2,6-ジクロロアニリン水酸化ナトリウム塩化アルミニウム(III)

下流製品

1-(2,6-ジクロロフェニル)-1H-インドール-2(3H)-オン2-(2,6-ジクロロアニリノ)フェニル酢酸メチルオキシインドール

補足説明

定義ChEBI: Diclofenac sodium is the sodium salt of diclofenac. It contains a diclofenac(1-).